These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28747357)

  • 1. An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease.
    Yanda MK; Liu Q; Cebotaru L
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F997-F1004. PubMed ID: 28747357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
    Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
    Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease.
    Lorenzo Pisarello M; Masyuk TV; Gradilone SA; Masyuk AI; Ding JF; Lee PY; LaRusso NF
    Am J Pathol; 2018 Apr; 188(4):981-994. PubMed ID: 29366679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca
    Yanda MK; Liu Q; Cebotaru V; Guggino WB; Cebotaru L
    J Biol Chem; 2017 Oct; 292(43):17897-17908. PubMed ID: 28887310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis.
    Gradilone SA; Habringer S; Masyuk TV; Howard BN; Masyuk AI; Larusso NF
    Am J Pathol; 2014 Mar; 184(3):600-8. PubMed ID: 24434010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
    Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
    J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease.
    Wang Q; Cobo-Stark P; Patel V; Somlo S; Han PL; Igarashi P
    Kidney Int; 2018 Feb; 93(2):403-415. PubMed ID: 29042084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice.
    Zhang L; Liu C; Wu J; Tao JJ; Sui XL; Yao ZG; Xu YF; Huang L; Zhu H; Sheng SL; Qin C
    J Alzheimers Dis; 2014; 41(4):1193-1205. PubMed ID: 24844691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model.
    He J; Zhang S; Qiu Z; Li X; Huang H; Jin W; Xu Y; Shao G; Wang L; Meng J; Wang S; Geng X; Jia Y; Li M; Yang B; Jenny Lu HA; Zhou H
    J Am Soc Nephrol; 2021 Sep; 32(9):2159-2174. PubMed ID: 34465607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACY 1215, a histone deacetylase 6 inhibitor, inhibits cancer cell growth in melanoma.
    Wang F; Zhong BW; Zhao ZR
    J Biol Regul Homeost Agents; 2018; 32(4):851-858. PubMed ID: 30043566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylases 6 increases the cyclic adenosine monophosphate level and promotes renal cyst growth.
    Wu M; Mei C
    Kidney Int; 2016 Jul; 90(1):20-2. PubMed ID: 27312442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector.
    Yanda MK; Liu Q; Cebotaru L
    J Biol Chem; 2018 Jul; 293(29):11513-11526. PubMed ID: 29875161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation.
    Fan LX; Li X; Magenheimer B; Calvet JP; Li X
    Kidney Int; 2012 Jan; 81(1):76-85. PubMed ID: 21900881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease.
    Benoy V; Vanden Berghe P; Jarpe M; Van Damme P; Robberecht W; Van Den Bosch L
    Neurotherapeutics; 2017 Apr; 14(2):417-428. PubMed ID: 27957719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics and autosomal dominant polycystic kidney disease.
    Li X
    Biochim Biophys Acta; 2011 Oct; 1812(10):1213-8. PubMed ID: 20970496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzothiazole derivatives as histone deacetylase inhibitors for the treatment of autosomal dominant polycystic kidney disease.
    Cao X; Fan Z; Xu L; Zhao W; Zhang H; Yang Y; Ren Y; Xiao Y; Zhou N; Yin L; Zhou X; Zhu X; Guo D
    Eur J Med Chem; 2024 May; 271():116428. PubMed ID: 38653068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase 6 inhibitor ACY-1215 protects against experimental acute liver failure by regulating the TLR4-MAPK/NF-κB pathway.
    Zhang WB; Zhang HY; Jiao FZ; Wang LW; Zhang H; Gong ZJ
    Biomed Pharmacother; 2018 Jan; 97():818-824. PubMed ID: 29112935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells.
    Liu W; Fan LX; Zhou X; Sweeney WE; Avner ED; Li X
    PLoS One; 2012; 7(11):e49418. PubMed ID: 23152903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice.
    Sakloth F; Manouras L; Avrampou K; Mitsi V; Serafini RA; Pryce KD; Cogliani V; Berton O; Jarpe M; Zachariou V
    Psychopharmacology (Berl); 2020 Jul; 237(7):2139-2149. PubMed ID: 32388618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease.
    Zhou X; Fan LX; Sweeney WE; Denu JM; Avner ED; Li X
    J Clin Invest; 2013 Jul; 123(7):3084-98. PubMed ID: 23778143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.